Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet
出版年份 2015 全文链接
标题
Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 6, Pages e0128648
出版商
Public Library of Science (PLoS)
发表日期
2015-06-23
DOI
10.1371/journal.pone.0128648
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
- (2013) Mariana Lazo et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- (2013) Ebenezer T. Oni et al. ATHEROSCLEROSIS
- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
- (2013) Giovanni Targher et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fructose as a key player in the development of fatty liver disease
- (2013) Metin Basaranoglu WORLD JOURNAL OF GASTROENTEROLOGY
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
- (2013) Melania Gaggini et al. Nutrients
- Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy
- (2012) Ashlee N. Higdon et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
- (2012) Manal F. Abdelmalek et al. HEPATOLOGY
- Heme Oxygenase Gene Targeting to Adipocytes Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet
- (2012) Jian Cao et al. HYPERTENSION
- Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-adipocytes
- (2012) Nitin Puri et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease
- (2012) Kyoko Nomura et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB
- (2012) Hui Yang WORLD JOURNAL OF GASTROENTEROLOGY
- Way back for fructose and liver metabolism: Bench side to molecular insights
- (2012) Alba Rebollo WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels
- (2011) Komal Sodhi et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- High fat diet enhances cardiac abnormalities in SHR rats: Protective role of heme oxygenase-adiponectin axis
- (2011) Jian Cao et al. Diabetology & Metabolic Syndrome
- Regulation of SIRT1 in cellular functions: Role of polyphenols
- (2010) Sangwoon Chung et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Insulin Resistance in Nonalcoholic Fatty Liver Disease
- (2010) E. Bugianesi et al. CURRENT PHARMACEUTICAL DESIGN
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- Lentiviral-Human Heme Oxygenase Targeting Endothelium Improved Vascular Function in Angiotensin II Animal Model of Hypertension
- (2010) Jian Cao et al. HUMAN GENE THERAPY
- Adipocyte Heme Oxygenase-1 Induction Attenuates Metabolic Syndrome in Both Male and Female Obese Mice
- (2010) Angela Burgess et al. HYPERTENSION
- The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
- (2010) Jung Sub Lim et al. Nature Reviews Gastroenterology & Hepatology
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study
- (2009) Leon A Adams et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice
- (2009) Yu Yamazaki et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
- (2009) Aparna Purushotham et al. Cell Metabolism
- Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-κB-Dependent Pathway
- (2009) Qianhong Li et al. CIRCULATION
- Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
- (2009) Richard J. Johnson et al. ENDOCRINE REVIEWS
- Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats
- (2009) Angelique Nicolai et al. HYPERTENSION
- The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice,
- (2009) Stephen J. Peterson et al. JOURNAL OF LIPID RESEARCH
- PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
- (2009) Jennifer L. Estall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk
- (2008) A. Burroughs et al. CURRENT PHARMACEUTICAL DESIGN
- Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity
- (2008) N. Abraham et al. CURRENT PHARMACEUTICAL DESIGN
- Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance
- (2008) M. Li et al. DIABETES
- Evolving trends in nonalcoholic fatty liver disease
- (2008) Jorge-Shmuel Delgado European Journal of Internal Medicine
- Heme Oxygenase-Mediated Increases in Adiponectin Decrease Fat Content and Inflammatory Cytokines Tumor Necrosis Factor- and Interleukin-6 in Zucker Rats and Reduce Adipogenesis in Human Mesenchymal Stem Cells
- (2008) D. H. Kim et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacological and Clinical Aspects of Heme Oxygenase
- (2008) N. G. Abraham et al. PHARMACOLOGICAL REVIEWS
- Non-alcoholic fatty liver disease and cardiovascular risk
- (2008) Tatjána Ábel et al. ORVOSI HETILAP
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now